Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,622,761
+$3,233,954 QoQ
Shares Held
131,133
+12.8% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#91
of 329 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. PCVX ranks #12 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
244,594 | $45,807,564 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
98,974 | $24,225,865 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
395,844 | $23,893,143 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
311,494 | $23,200,073 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
172,695 | $20,217,403 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
391,529 | $19,870,096 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
186,769 | $18,206,242 | |
| 8 | CYTK |
Cytokinetics Inc
|
209,071 | $17,810,758 |
All Filings in PCVX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,622,761 | 131,133 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $4,388,807 | 116,229 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,211,131 | 100,307 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,356,770 | 81,883 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,586,737 | 87,230 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,850,341 | 85,644 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,953,404 | 110,723 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $23,451,207 | 460,008 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,980,590 | 460,164 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $16,258,824 | 433,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,913,289 | 123,322 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||